An antibody-like peptide that recognizes malignancy among thyroid nodules

Cancer Letters

Volumn 335, Issue 2, 2013, Pages 306-313

  Reis, Carolina Fernandes ^a   Carneiro, Ana Paula ^a   Vieira, Carlos Ueira ^b   Fujimura, Patrícia Tiemi ^b   Morari, Elaine Cristina ^a   Silva, Sindeval José da ^b   Goulart, Luiz Ricardo ^b   Ward, Laura Sterian ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b FEDERAL UNIVERSITY OF UBERLÂNDIA   (Brazil)

Author keywords

Biomarker; Papillary tumor; Phage display; Thyroid cancer

Indexed keywords

ANTIBODY LIKE PEPTIDE; PEPTIDE; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIFFERENTIAL DIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; NODULAR GOITER; PHAGE DISPLAY; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEOMICS; SENSITIVITY AND SPECIFICITY; THYROID ADENOMA; THYROID CANCER; THYROID FOLLICULAR CARCINOMA; THYROID NODULE; THYROID PAPILLARY CARCINOMA; TISSUE MICROARRAY; TUMOR CELL LINE;

ADENOCARCINOMA, FOLLICULAR; AMINO ACID SEQUENCE; ANTIBODIES; BASE SEQUENCE; BREAST NEOPLASMS; CARCINOMA; CELL LINE, TUMOR; FEMALE; GOITER, NODULAR; HUMANS; KIDNEY NEOPLASMS; LIGANDS; MALE; PEPTIDES; PROSTATIC NEOPLASMS; PROTEIN BINDING; SEQUENCE ANALYSIS, DNA; THYROID GLAND; THYROID NEOPLASMS; THYROID NODULE; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84878241451     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2013.02.039     Document Type: Article

References (34)

1. Davies L., Welch H.G. Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA: J. Am. Med. Assoc. 2006, 295:2164-2167.
2. Siegel R., DeSantis C., Virgo K., Stein K., Mariotto A., Smith T., Cooper D., Gansler T., Lerro C., Fedewa S., Lin C., Leach C., Cannady R.S., Cho H., Scoppa S., Hachey M., Kirch R., Jemal A., Ward E. Cancer treatment and survivorship statistics. CA: Cancer J. Clin. 2012, 62:220-241.
3. Ward L.S., Graf H. Thyroid cancer: increased occurrence of the disease or simply in its detection?. Arq. Bras. endocrinol. Metabol. 2008, 52:1515-1516.
4. Aschebrook-Kilfoy B., Ward M.H., Sabra M.M., Devesa S.S. Thyroid cancer incidence patterns in the United States by histologic type, 1992-2006. Thyroid: Official J. Am. Thyroid Assoc. 2011, 21:125-134.
5. Cooper D.S., Doherty G.M., Haugen B.R., Kloos R.T., Lee S.L., Mandel S.J., Mazzaferri E.L., McIver B., Pacini F., Schlumberger M., Sherman S.I., Steward D.L., Tuttle R.M. Revised American thyroid association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid: Official J. Am. Thyroid Assoc. 2009, 19:1167-1214.
6. Bose S., Walts A.E. Thyroid fine needle aspirate: a post-Bethesda update. Adv. Anat. Pathol. 2012, 19:160-169.
7. Wang C.C., Friedman L., Kennedy G.C., Wang H., Kebebew E., Steward D.L., Zeiger M.A., Westra W.H., Wang Y., Khanafshar E., Fellegara G., Rosai J., Livolsi V., Lanman R.B. A large multicenter correlation study of thyroid nodule cytopathology and histopathology. Thyroid: Official J. Am. Thyroid Assoc. 2011, 21:243-251.
8. Alexander E.K., Kennedy G.C., Baloch Z.W., Cibas E.S., Chudova D., Diggans J., Friedman L., Kloos R.T., LiVolsi V.A., Mandel S.J., Raab S.S., Rosai J., Steward D.L., Walsh P.S., Wilde J.I., Zeiger M.A., Lanman R.B., Haugen B.R. Preoperative diagnosis of benign thyroid nodules with indeterminate cytology. New England J. Med. 2012, 367:705-715.
9. Yip L., Farris C., Kabaker A.S., Hodak S.P., Nikiforova M.N., McCoy K.L., Stang M.T., Smith K.J., Nikiforov Y.E., Carty S.E. Cost impact of molecular testing for indeterminate thyroid nodule fine-needle aspiration biopsies. J. Clin. Endocrinol. Metab. 2012, 97:1905-1912.
10. Carnazza S., Foti C., Gioffre G., Felici F., Guglielmino S. Specific and selective probes for Pseudomonas aeruginosa from phage-displayed random peptide libraries. Biosensors Bioelectron. 2008, 23:1137-1144.
11. Nicol C.G., Denby L., Lopez-Franco O., Masson R., Halliday C.A., Nicklin S.A., Kritz A., Work L.M., Baker A.H. Use of in vivo phage display to engineer novel adenoviruses for targeted delivery to the cardiac vasculature. FEBS Lett. 2009, 583:2100-2107.
12. Yu X., Owens G.P., Gilden D.H. Rapid and efficient identification of epitopes/mimotopes from random peptide libraries. J. Immunol. Methods 2006, 316:67-74.
13. Bai F., Liang J., Wang J., Shi Y., Zhang K., Liang S., Hong L., Zhai H., Lu Y., Han Y., Yin F., Wu K., Fan D. Inhibitory effects of a specific phage-displayed peptide on high peritoneal metastasis of gastric cancer. J. Mol. Med. (Berl) 2007, 85:169-180.
14. Chen L., Wang Y., Liu X., Dou S., Liu G., Hnatowich D.J., Rusckowski M. A new TAG-72 cancer marker peptide identified by phage display. Cancer Lett. 2008, 272:122-132.
15. Du B., Qian M., Zhou Z., Wang P., Wang L., Zhang X., Wu M., Zhang P., Mei B. In vitro panning of a targeting peptide to hepatocarcinoma from a phage display peptide library. Biochem. Biophys. Res. Commun. 2006, 342:956-962.
16. Dybwad A., Lambin P., Sioud M., Zouali M. Probing the specificity of human myeloma proteins with a random peptide phage library. Scand. J. Immunol. 2003, 57:583-590.
17. Goenaga A.L., Zhou Y., Legay C., Bougherara H., Huang L., Liu B., Drummond D.C., Kirpotin D.B., Auclair C., Marks J.D., Poul M.A. Identification and characterization of tumor antigens by using antibody phage display and intrabody strategies. Mol. Immunol. 2007, 44:3777-3788.
18. Hu S., Guo X., Xie H., Du Y., Pan Y., Shi Y., Wang J., Hong L., Han S., Zhang D., Huang D., Zhang K., Bai F., Jiang H., Zhai H., Nie Y., Wu K., Fan D. Phage display selection of peptides that inhibit metastasis ability of gastric cancer cells with high liver-metastatic potential. Biochem. Biophys. Res. Commun. 2006, 341:964-972.
19. Liang S., Lin T., Ding J., Pan Y., Dang D., Guo C., Zhi M., Zhao P., Sun L., Hong L., Shi Y., Yao L., Liu J., Wu K., Fan D. Screening and identification of vascular-endothelial-cell-specific binding peptide in gastric cancer. J. Mol. Med. (Berl) 2006, 84:764-773.
20. Matsuo A.L., Tanaka A.S., Juliano M.A., Rodrigues E.G., Travassos L.R. A novel melanoma-targeting peptide screened by phage display exhibits antitumor activity. J. Mol. Med. (Berl) 2010, 88:1255-1264.
21. Mazuet C., Lerouge D., Poul M.A., Blin N. Breast carcinoma specific antibody selection combining phage display and immunomagnetic cell sorting. Biochem. Biophys. Res. Commun. 2006, 348:550-559.
22. Jia W.D., Sun H.C., Zhang J.B., Xu Y., Qian Y.B., Pang J.Z., Wang L., Qin L.X., Liu Y.K., Tang Z.Y. A novel peptide that selectively binds highly metastatic hepatocellular carcinoma cell surface is related to invasion and metastasis. Cancer Lett. 2007, 247:234-242.
23. Oyama T., Sykes K.F., Samli K.N., Minna J.D., Johnston S.A., Brown K.C. Isolation of lung tumor specific peptides from a random peptide library: generation of diagnostic and cell-targeting reagents. Cancer Lett. 2003, 202:219-230.
24. Zang L., Shi L., Guo J., Pan Q., Wu W., Pan X., Wang J. Screening and identification of a peptide specifically targeted to NCI-H1299 from a phage display peptide library. Cancer Lett. 2009, 281:64-70.
25. Giordano R.J., Cardo-Vila M., Lahdenranta J., Pasqualini R., Arap W. Biopanning and rapid analysis of selective interactive ligands. Nat. Med. 2001, 7:1249-1253.
26. Huang J., Ru B., Dai P. Bioinformatics resources and tools for phage display. Molecules 2011, 16:694-709.
27. Mandava S., Makowski L., Devarapalli S., Uzubell J., Rodi D.J. RELIC - a bioinformatics server for combinatorial peptide analysis and identification of protein-ligand interaction sites. Proteomics 2004, 4:1439-1460.
28. Du B., Han H., Wang Z., Kuang L., Wang L., Yu L., Wu M., Zhou Z., Qian M. Targeted drug delivery to hepatocarcinoma in vivo by phage-displayed specific binding peptide. Mol. Cancer Res.: MCR 2010, 8:135-144.
29. de Matos P.S., Ferreira A.P., de Oliveira Facuri F., Assumpcao L.V., Metze K., Ward L.S. Usefulness of HBME-1, cytokeratin 19 and galectin-3 immunostaining in the diagnosis of thyroid malignancy. Histopathology 2005, 47:391-401.
30. Sethi K., Sarkar S., Das S., Mohanty B., Mandal M. Biomarkers for the diagnosis of thyroid cancer. J. Exp. Therap. Oncol. 2010, 8:341-352.
31. Barbas C.F. Phage Display: a Laboratory Manual 2001, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
32. Zwick M.B., Bonnycastle L.L., Noren K.A., Venturini S., Leong E., Barbas C.F., Noren C.J., Scott J.K. The maltose-binding protein as a scaffold for monovalent display of peptides derived from phage libraries. Anal. Biochem. 1998, 264:87-97.
33. Giovanella L., Ceriani L., Ghelfo A., Maffioli M. Circulating cytokeratin 19 fragments in patients with benign nodules and carcinomas of the thyroid gland. Int. J. Biol. Markers 2008, 23:54-57.
34. Appetecchia M., Mecule A., Ducci M., Palma L., Castelli M. Serum cytokeratins determination in differentiated thyroid carcinoma. J. Exp. Clin. Cancer Res.: CR 2001, 20:253-256.